药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Podofilox
Guselkumab
The risk or severity of adverse effects can be increased when Pazopanib is combined with Guselkumab.
Podofilox
Sirukumab
The risk or severity of adverse effects can be increased when Pazopanib is combined with Sirukumab.
Podofilox
Brodalumab
The risk or severity of adverse effects can be increased when Pazopanib is combined with Brodalumab.
Podofilox
Peficitinib
The risk or severity of adverse effects can be increased when Pazopanib is combined with Peficitinib.
Podofilox
Voclosporin
The risk or severity of adverse effects can be increased when Pazopanib is combined with Voclosporin.
Podofilox
Pirarubicin
The risk or severity of adverse effects can be increased when Pazopanib is combined with Pirarubicin.
Podofilox
Ravulizumab
The risk or severity of adverse effects can be increased when Pazopanib is combined with Ravulizumab.
Podofilox
Ixekizumab
The risk or severity of adverse effects can be increased when Pazopanib is combined with Ixekizumab.
Podofilox
Melengestrol
The risk or severity of adverse effects can be increased when Pazopanib is combined with Melengestrol.
Podofilox
Tepoxalin
The risk or severity of adverse effects can be increased when Pazopanib is combined with Tepoxalin.
Podofilox
Fluprednisolone
The risk or severity of adverse effects can be increased when Pazopanib is combined with Fluprednisolone.
Podofilox
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Pazopanib is combined with Antilymphocyte immunoglobulin (horse).
Podofilox
Peginterferon beta-1a
The risk or severity of adverse effects can be increased when Pazopanib is combined with Peginterferon beta-1a.
Podofilox
Tixocortol
The risk or severity of adverse effects can be increased when Pazopanib is combined with Tixocortol.
Podofilox
Vilanterol
The risk or severity of adverse effects can be increased when Pazopanib is combined with Vilanterol.
Podofilox
Dinutuximab
The risk or severity of adverse effects can be increased when Pazopanib is combined with Dinutuximab.
Podofilox
Blinatumomab
The risk or severity of adverse effects can be increased when Pazopanib is combined with Blinatumomab.
Podofilox
Vedolizumab
The risk or severity of adverse effects can be increased when Pazopanib is combined with Vedolizumab.
Podofilox
Obinutuzumab
The risk or severity of adverse effects can be increased when Pazopanib is combined with Obinutuzumab.
Podofilox
Dimethyl fumarate
The risk or severity of adverse effects can be increased when Pazopanib is combined with Dimethyl fumarate.